Current Alzheimer Research, Volume 11 - Number 7


Editorial (Thematic Issue: Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD)

, 11(7): 623 - 625

Scott E. Counts and Debomoy K. Lahiri

DOI: 10.2174/156720501107140815102453

Intravenous Immunoglobulins for Alzheimer's Disease

, 11(7): 626 - 636

Lakshman Puli, Heikki Tanila and Norman Relkin

DOI: 10.2174/1567205011666140812113415

Role of Complement Systems in IVIG Mediated Attenuation of Cognitive Deterioration in Alzheimer's Disease

, 11(7): 637 - 644

Bing Gong, Samara Levine, Scott R. Barnum and Giulio M. Pasinetti

DOI: 10.2174/1567205011666140812113707

Intravenous Immunoglobulin Treatment Preserves and Protects Primary Rat Hippocampal Neurons and Primary Human Brain Cultures Against Oxidative Insults

, 11(7): 645 - 654

Debomoy K. Lahiri and Balmiki Ray

DOI: 10.2174/1567205011666140812113851

Intravenous Immunoglobulin Reduces Tau Pathology and Preserves Neuroplastic Gene Expression in the 3xTg Mouse Model of Alzheimer`s Disease

, 11(7): 655 - 663

Scott E. Counts, Sylvia E. Perez, Bin He and Elliott J. Mufson

DOI: 10.2174/1567205011666140812114037

Intraventricular Human Immunoglobulin Distributes Extensively but Fails to Modify Amyloid in a Mouse Model of Amyloid Deposition

, 11(7): 664 - 671

Aurelie Joly-Amado, Milene Brownlow, Jacob Pierce, Advaitaa Ravipati, Erin Showalter, Qingyou Li, Marcia N Gordon and Dave Morgan

DOI: 10.2174/1567205011666140812114341

Fluoxetine Improves Behavioral Performance by Suppressing the Production of Soluble β-Amyloid in APP/PS1 Mice

, 11(7): 672 - 680

Junhui Wang, Yanbo Zhang, Haiyun Xu, Shenghua Zhu, Hongxing Wang, Jue He, Handi Zhang, Huining Guo, Jiming Kong, Qingjun Huang and Xin-Min Li

DOI: 10.2174/1567205011666140812114715

Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late- Life (Age 65-84 Years): A Population Based Case-Control Study

, 11(7): 681 - 693

Renate R. Zilkens, David G. Bruce, Janine Duke, Katrina Spilsbury and James B. Semmens

DOI: 10.2174/1567205011666140812115004

Metabotropic Glutamate Receptor 5 in Down's Syndrome Hippocampus During Development: Increased Expression in Astrocytes

, 11(7): 694 - 705

A.M. Iyer, J. van Scheppingen, I. Milenkovic, J.J. Anink, D. Lim, A.A. Genazzani, H. Adle-Biassette, G. G. Kovacs and E. Aronica

DOI: 10.2174/1567205011666140812115423

Bone Loss and Osteoporosis are Associated with Conversion from Mild Cognitive Impairment to Alzheimer’s Disease

, 11(7): 706 - 713

Rui Zhou, Huadong Zhou, Li Rui and Jianzhong Xu

DOI: 10.2174/1567205011666140812115818

CHF5074 Protects SH-SY5Y Human Neuronal-like Cells from Amyloidbeta 25-35 and Tumor Necrosis Factor Related Apoptosis Inducing Ligand Toxicity In Vitro

, 11(7): 714 - 724

Nicole Ronsisvalle, Giulia Di Benedetto, Carmela Parenti, Salvatore Amoroso, Renato Bernardini and Giuseppina Cantarella

DOI: 10.2174/1567205011666140618104430

Webmaster Contact:
Copyright © 2018 Bentham Science